Related Experiment Video
Updated: May 13, 2026

An Open-Source Normothermic Perfusion System Designed for Research Scientists
Published on: July 18, 2025
Hemolysis in extracorporeal circulation: relationship between time and procedures
Francisco Ubaldo Vieira Junior1, Nilson Antunes, Reinaldo Wilson Vieira
1State University of Campinas, Instituto Federal de São Paulo, Brazil. fubaldo@terra.com.br
Insights
The initial five minutes of extracorporeal circulation (EC) during coronary artery bypass grafting cause the highest rate of blood hemolysis. Hemolysis rates remained stable during aortic suction and residual volume passage.
Area of Science:
- Cardiovascular Surgery
- Hemodynamics
- Blood Compatibility
Background:
- Extracorporeal circulation (EC) is a critical component of modern cardiac surgery.
- However, EC is associated with significant blood trauma, notably hemolysis.
- Understanding hemolysis during EC is vital for patient safety and outcomes.
Purpose of the Study:
- To quantify the rate of hemolysis at various time points during EC.
- Specifically, to assess hemolysis during elective coronary artery bypass grafting (CABG).
Main Methods:
- Hemolysis rates were measured in 22 patients undergoing myocardial revascularization with EC.
- Measurements were taken at six distinct time points: pre-EC, 5 minutes post-initiation, 30 minutes, pre-aortic unclamping, pre-residual volume passage, and 5 minutes post-passage.
- Hemolysis rates were calculated across defined intervals.
Main Results:
- The highest rate of hemolysis was observed within the first five minutes of EC initiation (P = 0.0003).
- This initial period accounted for 29% of the total hemolysis observed up to the point of residual volume passage.
- No significant hemolysis changes were noted during aortic root suction or residual volume management.
Conclusions:
- The early phase of extracorporeal circulation presents the highest risk for hemolysis.
- Hemolysis rates are not significantly affected by aortic suction or the method of residual volume return.
- These findings highlight the importance of monitoring and potentially mitigating hemolysis during the initial stages of EC.
Introduction:
Extracorporeal circulation (EC) is very important in cardiac surgery but causes significant damage to the blood, including hemolysis.
Objective:
To quantify the rate of hemolysis at different times during EC in elective coronary artery bypass grafting.
Methods:
We measured rates of hemolysis of 22 patients at 6 different times during myocardial revascularization during EC: T0 - before the start of EC, T1 - five minutes after of the EC initiation, T2 - 30 minutes of EC, T3 - immediately before the aortic unclamping, T4 - immediately before passage of the residual volume to the patient and T5 - five minutes after the passage of the residual volume to the patient. Rates of hemolysis were calculated between the intervals of time: T0-T1; T1-T2; T2-T3; T3-T4 and T4-T5.
Results:
The first 5 minutes after the EC showed the highest rate of hemolysis (P = 0.0003) compared to the others calculated rates, representing 29% of the total haemolysis until T4 (Immediately before passage of the residual volume to the patient).
Conclusion:
There were no significant changes in the rate of hemolysis during the suction in the aortic root (P> 0.38), nor with the procedure used for the passage of the residual volume of blood in the circuit to the patient.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis II: Procedure and Complications
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
